Kavuklu B, Iskit A B, Guc M O, Ilhan M, Sayek I
Departments of General Surgery and Pharmacology, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey.
Br J Surg. 2000 Apr;87(4):448-53. doi: 10.1046/j.1365-2168.2000.01376.x.
The aim of this study was to investigate the effects of inducible nitric oxide synthase inhibition by aminoguanidine on endotoxin-induced reduction in mesenteric blood flow.
Twenty Sprague-Dawley rats (180-230 g) allocated into four groups were administered either Escherichia coli endotoxin 1 mg/kg intraperitoneally or its solvent saline and were pretreated with either aminoguanidine (15 mg/kg intraperitoneally 20 min before and 2 h after endotoxin injection) or saline. Some 4 h after endotoxin injection, animals were anaesthetized, arterial blood pressure and mesenteric blood flow were measured and the resistance in the mesenteric vascular beds was then calculated. The effect of phenylephrine (1-30 microg/kg intravenously) on these parameters was also investigated.
Endotoxin did not significantly modify the mean arterial blood pressure but decreased mesenteric blood flow by increasing the vascular resistance (mean(s.e.m.) 7.8(1.0) versus 13.7(1.2) mmHg per min per ml for control versus endotoxin groups; n = 5, P = 0.0099). Aminoguanidine alone had no effect on either the mean arterial blood pressure or mesenteric blood flow, but it completely blocked the effects of endotoxin. On the other hand, endotoxin significantly attenuated the responsiveness to phenylephrine which was restored by aminoguanidine.
The present results indicate that endotoxin decreases the mesenteric vascular blood flow by increasing vascular resistance and decreases responsiveness to phenylephrine. The effects of endotoxin were inhibited by aminoguanidine. The mesenteric vasoconstriction in response to endotoxin might not be explained by the overproduction of nitric oxide; other actions of aminoguanidine may explain its inhibitory effect. Presented in part to the 10th Annual Meeting of the Surgical Infection Society - Europe, Istanbul, Turkey, May 1997
本研究旨在探讨氨基胍抑制诱导型一氧化氮合酶对内毒素所致肠系膜血流量减少的影响。
将20只体重180 - 230克的Sprague-Dawley大鼠分为四组,分别腹腔注射1毫克/千克大肠杆菌内毒素或其溶剂生理盐水,并分别用氨基胍(内毒素注射前20分钟及注射后2小时腹腔注射15毫克/千克)或生理盐水预处理。内毒素注射约4小时后,将动物麻醉,测量动脉血压和肠系膜血流量,然后计算肠系膜血管床的阻力。还研究了去氧肾上腺素(静脉注射1 - 30微克/千克)对这些参数的影响。
内毒素对平均动脉血压无显著影响,但通过增加血管阻力降低了肠系膜血流量(对照组与内毒素组分别为每分钟每毫升7.8(1.0)与13.7(1.2)毫米汞柱;n = 5,P = 0.0099)。单独使用氨基胍对平均动脉血压或肠系膜血流量均无影响,但它完全阻断了内毒素的作用。另一方面,内毒素显著减弱了对去氧肾上腺素的反应性,而氨基胍可使其恢复。
目前的结果表明,内毒素通过增加血管阻力降低肠系膜血管血流量,并降低对去氧肾上腺素的反应性。氨基胍可抑制内毒素的作用。内毒素引起的肠系膜血管收缩可能无法用一氧化氮过量产生来解释;氨基胍的其他作用可能解释其抑制作用。部分内容曾在1997年5月于土耳其伊斯坦布尔举行的欧洲外科感染学会第十届年会上发表